IRCT20221126056616N1Recruiting
Investigating and Comparing the Association of Fatty Liver with Tamoxifen and Letrozole in Premenopausal Patients with Breast Cancer
Qazvin University of Medical SciencesPhase 2Iranian Registry Of Clinical Trialdrug
VerifiedIranian Registry Of Clinical Trial
Study focus
- Disease/Condition
- Malignant neoplasm of breast
- Study type
- Interventional
- Intervention type
- drug
Sponsor & location
- Primary sponsor
- Qazvin University of Medical Sciences
- Location
- Iran
Timeline & enrollment
- Phase
- Phase 2
- Start date
- Dec 22, 2022
- End date
- N/A
ICD-10 classifications
Malignant neoplasm of breastMalignant neoplasm of breastMalignant neoplasm: Breast, unspecifiedMalignant neoplasm: Central portion of breastPersonal history of malignant neoplasm of breast
Data source
- Registry
- Iranian Registry Of Clinical Trial
- Trial ID
- IRCT20221126056616N1
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for IRCT20221126056616N1 through Pure Global AI's free database. This Phase 2 trial is sponsored by Qazvin University of Medical Sciences and is currently Recruiting. The study focuses on Malignant neoplasm of breast.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.